213
Participants
Start Date
January 8, 2020
Primary Completion Date
September 7, 2020
Study Completion Date
September 29, 2020
Tiotropium + olodaterol
Oral Inhalation
Placebo
Oral Inhalation
CHEAR Center LLC, The Bronx
Klinische Forschung Berlin GbR, Berlin
Hamburger Institut für Therapieforschung GmbH (HIT), Hamburg
Pneumologisches Forschungsinstitut an der LungenClinic Grosshansdorf GmbH, Großhansdorf
KLB Gesundheitsforschung Lübeck GmbH, Lübeck
Southeastern Research Center, Winston-Salem
North Carolina Clinical Research, Raleigh
Vitalink Research - Spartansburg, Spartanburg
Carolina Medical Research, Clinton
VitaLink Research -Gaffney, Gaffney
Lowcountry Lung and Critical Care, Charleston
Meris Clinical Research, Brandon
Clinical Research of West Florida, Inc., Tampa
Clinical Research of West Florida, Inc., Clearwater
Clinical Research Specialists LLC, Kissimmee
Jasper Summit Research, LLC, Jasper
SEC Lung, Andalusia
Bernstein Clinical Rsrch Ctr, Cincinnati
Pulmonary Rsrch Inst of SE MI, Farmington Hills
Minnesota Lung Center, Woodbury
Minnesota Lung Center and Sleep Institute, Edina
IKF Pneumologie GmbH & Co. KG, Frankfurt
Best Clinical Trials, LLC, New Orleans
Diagnostics Research Group, San Antonio
Infinity Medical Research, North Dartmouth
Valley Regional Hospital, Claremont
Lead Sponsor
Boehringer Ingelheim
INDUSTRY